1. Akbar, A.N., Terry, L., Timms, A., Beverley, P.C., and Janossy, G., Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells, J. Immun., 1988, vol. 140, pp. 2171–2178.
2. Arana-Argaez, V.E., Delgado-Rizo, V., Pizano-Martinez, O.E., Martinez-Garcia, E.A., Martin-Marquez, B.T., Munoz-Gomez, A., Petri, M.H., Armendariz-Borunda, J., Espinosa-Ramirez, G., Zuniga-Tamayo, D.A., Herrera-Esparza, R., and Mercado, M., Inhibitors of MAPK pathway ERK1/2 or p38 prevent the IL-1-induced up-regulation of SRP72 autoantigen in Jurkat cells, J. Biol. Chem., 2010, vol. 285, pp. 32824–32833.
3. Au, A., Ha, J., Hernandez, M., Polotsky, A., Hungerford, D.S., and Frondoza, C.G., Nickel and vanadium metal ions induce apoptosis of T-lymphocyte Jurkat cells, J. Biomed. Mater. Res., 2006, vol. A 79, no. 3, pp. 512–521.
4. Baggiolini, M. and Clark-Lewis, I., Interleukin-8, a Chemotactic and Inflammatory Cytokine: Minireview, FEBS, 1992, vol. 307, pp. 97–101.
5. Bi, B.Y., Lefebvre, A.M., Dus, D., Spik, G., and Mazurier, J., Effect of lactoferrin on proliferation and differentiation of the Jurkat human lymphoblastic T cell line, Arch. Immunol. Ther. Exp. (Warsz.), 1997, vol. 45, pp. 315–320.